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ABSTRACT Cell invasion targets specific tissues in physiological placental implantation and 
pathological metastasis, which raises questions about how this process is controlled. We 
compare dermis and endometrium capacities to support trophoblast invasion, using match-
ing sets of human primary fibroblasts in a coculture assay with human placental explants. 
Substituting endometrium, the natural trophoblast target, with dermis dramatically reduces 
trophoblast interstitial invasion. Our data reveal that endometrium expresses a higher rate of 
the fibronectin (FN) extra type III domain A+ (EDA+) splicing isoform, which displays stronger 
matrix incorporation capacity. We demonstrate that the high FN content of the endometrium 
matrix, and not specifically the EDA domain, supports trophoblast invasion by showing that 
forced incorporation of plasma FN (EDA–) promotes efficient trophoblast invasion. We fur-
ther show that the serine/arginine-rich protein serine/arginine-rich splicing factor 1 (SRSF1) is 
more highly expressed in endometrium and, using RNA interference, that it is involved in the 
higher EDA exon inclusion rate in endometrium. Our data therefore show a mechanism by 
which tissues can be distinguished, for their capacity to support invasion, by their different 
rates of EDA inclusion, linked to their SRSF1 protein levels. In the broader context of cancer 
pathology, the results suggest that SRSF1 might play a central role not only in the tumor cells, 
but also in the surrounding stroma.
INTRODUCTION
Cell invasion is a natural process required for the tissue-remodeling 
events that occur during physiological processes such as embryonic 
development and placental implantation. Failure to properly regu-
late cell invasion is responsible for life-threatening pathological con-
ditions such as cancer metastases. Despite the abundance of data 
on the regulation of epithelial cell migration, essential questions re-
main partly unanswered. In particular, the set of cues received from 
the stromal microenvironment that determines epithelial cell migra-
tion properties and, in the case of cancer progression, metastasis 
migration endpoints, remains elusive. In other words, it is still un-
clear why some organs appear more prone than others to invasion 
by given epithelial cells, as has long been known for cancer metas-
tases (Paget, 1889). Several hypotheses have been considered, in-
volving both cellular and noncellular components of the microenvi-
ronment (Joyce and Pollard, 2009; Nguyen et al., 2009; Friedl and 
Alexander, 2011). Among the latter, the stroma-derived extracellular 
matrix (ECM), and more specifically the interstitial matrix, could be 
determinant in selectively providing the appropriate migration scaf-
fold for given sets of epithelial cells (Lu et al., 2012).
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coculture of human placental explants and primary endometrial fi-
broblasts. Because fibroblasts from different human anatomical sites 
display distinct transcriptional patterns (Chang et al., 2002; Rinn 
et al., 2006), we investigated whether the substitution of human en-
dometrium fibroblasts with fibroblasts from an unrelated close-by 
human organ could affect trophoblast invasion properties. Using 
matching sets of tissue samples from patients, we found that dermis 
is much less efficient than endometrium in supporting trophoblast 
interstitial migration, a phenomenon related to the fibronectin con-
tent of the extracellular matrix of these tissues. Fibroblasts from hu-
man endometrium expressed more of the EDA+ fibronectin-splicing 
isoform, resulting in denser fibronectin meshworks and a higher ca-
pacity to support efficient trophoblast invasion. Of note, we found 
that the higher expression rate of the fibronectin EDA+ splicing iso-
form in endometrium results from higher expression levels of the SR 
protein SRSF1 in fibroblasts from this tissue. These data show how, 
through alternative splicing, the cellular concentrations of the splic-
ing factor SRSF1 can give unique properties to tissues and enable 
host cell invasion.
RESULTS
Endometrial and dermal fibroblasts exhibit distinct 
capacities in fostering trophoblast interstitial migration
We previously set up an ex vivo model system mimicking human 
placental implantation (Fafet et al., 2008). It is based on the 
coculture of primary endometrial fibroblasts and explants from 
4- to 7-wk placentas. To investigate the role of the stromal cell 
matrix for EVCT migration, we tested the effect of the substitu-
tion of endometrium with the unrelated, but close-by, subpubic 
dermis tissue. For that purpose, we isolated matching sets of pri-
mary human fibroblasts from dermis and endometrium specimens 
obtained from four different patients undergoing C-sections. 
Cocultures were set up between placental villi and fibroblasts iso-
lated either from endometrium (the biologically relevant tissue) 
or dermis. Trophoblast migration was then followed by phase-
contrast time-lapse microscopy (Figure 1A and Supplemental 
Videos S1 and S2). As we previously observed (Fafet et al., 2008), 
trophoblast explants attached to the endometrial fibroblast layer 
and within 24 h produced EVCTs that demonstrated the capacity 
to individually migrate within the endometrial fibroblast layer, 
away from the trophoblast explants that remained immobile 
(Figure 1A, left). On dermis, however, we unexpectedly observed 
further movement of the attached trophoblast villi (see left villus 
movement indicated by arrowheads). Most of all, EVCTs displayed 
a superficial migration on the dermis fibroblast layer instead of 
the interstitial EVCT migration observed with endometrial fibro-
blasts (Figure 1A, right). Time-lapse experiments, with pictures 
taken every 8 min for 24–48 h, were decisive in understanding 
this phenomenon of superficial migration of EVCTs that were 
characterized by high refringency and could eventually detach 
from the underlying dermis fibroblast layer. Phase-contrast time-
lapse microscopy was performed on trophoblastic villi from two 
other placentas and led to similar observations (data not shown). 
To confirm and quantify these trophoblast migration differences, 
we tested three additional placentas and three different sets of 
fibroblasts (from both endometrium and dermis). Phase-contrast 
images of the cocultures were taken 24 h apart, and both villi 
movement and trophoblast superficial migration between these 
two time points were scored (Figure 1B). As observed in the 
time-lapse experiments, villi movements occurred more fre-
quently on dermis (37% of the villi) than on endometrium (15%). 
Similarly, EVCT superficial migration occurred for 60% of the villi 
Interactions between cells and their neighboring extracellular 
matrix network are highly dynamic and essential for the determina-
tion of cell behavior. The extracellular matrix consists of a heteroge-
neous network of fibrillar and nonfibrillar components whose as-
sembly into functional structures appears highly regulated (Frantz 
et al., 2010). Collagens and fibronectin (FN) are major proteins of 
the connective tissue. Collagen fibrillogenesis occurs through com-
plex interactions with noncollagenous molecules such as fibronec-
tin, and the assembly of both collagen and fibronectin into fibrillar 
networks relies on interactions with cell surface integrin receptors 
(Mao and Schwarzbauer, 2005; Sottile et al., 2007; Kadler et al., 
2008; Singh et al., 2010). Different collagen proteins, expressed 
from different genes, have been described, including the fibril-form-
ing collagens I–III and V and the basement membrane collagen IV 
(Heino, 2007). In contrast, the various fibronectin isoforms found in 
the cellular environment result from the alternative splicing of a 
unique fibronectin-encoding gene at three sites: extra type III do-
main A (EDA)/EIIIA, EDB/EIIIB, and IIICS/V (White et al., 2008). The 
essential biological role played by FN and the EDA and EDB do-
mains is supported by the embryonic lethality associated with both 
the FN knockout and the double deletion of the EDA and EDB ex-
ons (George et al., 1993; Astrof et al., 2007; White et al., 2008). The 
fibronectin EDA domain favors the formation of extensive fibrous 
networks that participate in the insoluble extracellular matrix. The 
EDA+ fibronectin is therefore referred to as cellular fibronectin (cFN; 
Manabe et al., 1997; Abe et al., 2005; Mao and Schwarzbauer, 2005; 
Zoppi et al., 2012). In contrast, the plasma FN (pFN) lacks both EDA 
and EDB exons and remains mostly soluble even though it can be 
incorporated, like cFN, into insoluble matrix (McKeown-Longo and 
Etzler, 1987; Peters et al., 1990; Moretti et al., 2007). The EDA con-
taining fibronectin variant, also called fetal fibronectin for its expres-
sion during embryogenesis, is reexpressed in adult cells during tis-
sue repair, tumor progression, and inflammation. The inclusion of 
the EDA domain depends on RNA secondary structure (Buratti and 
Baralle, 2004) and the recruitment and phosphorylation status of the 
Ser/Arg-rich (SR) protein serine/arginine-rich splicing factor 1 (SRSF1; 
alternative splicing factor/splicing factor 2; Mermoud et al., 1994; 
Cramer et al., 1997, 1999; Misteli et al., 1997, 1998; Kadener et al., 
2002; Nogués et al., 2003; Blaustein et al., 2009; Chen and Manley, 
2009; de la Mata et al., 2010; White et al., 2010) and is facilitated by 
a reduced pol II elongation rate (de la Mata et al., 2003, 2010; 
Munoz et al., 2010).
Placental implantation during pregnancy relies on the invasive 
capacity of trophoblast cells produced by the trophectoderm of the 
blastocyst. Trophoblast invasion of the maternal endometrium rep-
resents a natural invasion process that enables efficient placental 
implantation and subsequent nurturing of the developing embryo 
(Norwitz et al., 2001). Invasive trophoblast and cancer cells share 
striking similarities in their migration capacities and dependence on 
the surrounding stroma, albeit with the notable difference of an in-
vasion process that remains controlled both in time and space in the 
case of placental implantation (Soundararajan and Rao, 2004). Of 
interest, in humans, the differentiation of the cytotrophoblast cells 
present in the placental villi into the invasive extravillous cytotropho-
blast cells (EVCTs) is accompanied by an up-regulation of the ex-
pression of the laminin/collagen receptor α1β1 and fibronectin-
binding integrin α5β1 (Damsky et al., 1994; Aplin et al., 1999; Harris 
et al., 2009).
To study the regulation of epithelial cell invasion, we previously 
developed a model system based on the invasion of the endome-
trial stroma by trophoblastic cells that occurs during human placen-
tal implantation (Fafet et al., 2008). This system is based on the 
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EVCTs exhibit different cytoskeleton 
structures and integrin expression 
patterns depending on whether they 
migrate on endometrium or dermis 
fibroblasts
We next asked whether the differences in 
EVCT migration patterns on dermis and en-
dometrium were linked to differences in 
EVCT cytoskeleton and adhesion protein 
expression patterns. To address this, we 
performed confocal immunofluorescence 
microscopy of the cocultures (Figure 2). 
Striking differences were found in the tro-
phoblast F-actin networks. EVCTs migrating 
on dermis fibroblasts could readily be iden-
tified by their well-defined actin bundles, a 
feature that was not observed on endome-
trium for EVCTs, otherwise identified by cy-
tokeratin 7 expression (Figure 2A). The tro-
phoblast integrin repertoire shifts from α6β4 
within the villi to α1β1 and α5β1 during 
EVCT migration (Harris et al., 2009). Consis-
tent with this, we detected EVCT expression 
of both integrins α5 and α1 in the cocul-
tures. Of interest, integrin α5 and α1 stain-
ing also underlined the formation of multiple 
cellular protrusions for EVCTs migrating on 
dermis compared with EVCTs migrating on 
endometrium (Figure 2, B and C). These 
data confirm the differences in EVCT migra-
tion characteristics depending on the type 
of fibroblasts—dermis or endometrium—
that support their migration.
Dermis and endometrium fibroblasts 
express different ECM components
To understand the molecular bases for the 
different capacities of endometrium and 
dermis fibroblasts to support EVCT intersti-
tial migration, we further characterized 
these fibroblasts for their expression of 
adhesion molecules and ECM components. 
Phase-contrast microscopy showed that 
dermis fibroblasts exhibited a distinct cell 
morphology, with a smoother membrane 
outline than endometrial fibroblasts (Figure 
3). The adhesion pattern of the two types 
of fibroblasts also differed, as shown by the 
expression pattern of vinculin and integrin 
αV, an integrin highly expressed by both 
types of fibroblasts. Instead of the staining 
observed throughout the cell surface for 
endometrial fibroblasts, these proteins 
were found clustered into elongated pe-
ripheral structures in dermis fibroblasts 
(Figure 3). These differences prompted 
us to determine, by reverse transcription- 
quantitative PCR (RT-qPCR), the expression 
levels of ECM and adhesion proteins in both types of fibroblasts. 
Four sets of dermis and endometrium fibroblasts from four differ-
ent donors were used. The expression levels of adhesion proteins 
and of most of the ECM components were found to be similar in 
on dermis in comparison to only 30% on endometrium. Taken 
together, these findings indicate that endometrium and dermis 
fibroblasts display different capacities in supporting EVCT inter-
stitial migration.
FIGURE 1: Endometrium and dermis fibroblasts show distinct capacities in fostering EVCT 
migration. Human placental explants were seeded on confluent layers of endometrium or 
dermis human primary fibroblasts. Sixteen hours later, the culture plates were rinsed several 
times to discard all unbound villi. (A) Migration of EVCTs produced by the trophoblast villi was 
followed by phase-contrast time-lapse microscopy of camera-scanned fields (nine contiguous 
fields). T0 is the beginning of the time lapse. Left, EVCTs exiting from the trophoblast villi and 
migrating with the endometrium cell layer (EVCT migration movements indicated by arrows; see 
Supplemental Video S1). On dermis (right), movement of the villi explants were observed 
(arrowheads), and EVCT cells appeared much more refringent and performed a superficial 
migration instead of the interstitial migration observed on endometrium (Supplemental Video 
S2). Bar, 300 μm. Similar findings were obtained with two other placentas. (B) Statistical analysis 
of trophoblastic villi mobility and EVCT superficial migration for cocultures with either 
endometrium or dermis fibroblasts. Data were obtained with trophoblastic villi (290 analyzed on 
endometrium and 240 on dermis) isolated from three placentas (in addition to the three 
placentas used in the time-lapse experiments) and three matching sets of fibroblasts, altogether 
used in five different combinations. Phase-contrast images of the cocultures were taken 24 h 
after seeding the trophoblastic explants and again 24 h later. Villi movement and EVCT 
superficial migration between these two time points were evaluated. Mean values with SEM. 
Two-tailed p values were determined with the Mann–Whitney rank sum test; **p = 0.008; 
*p = 0.01.
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in endometrium but barely detectable in dermis. Collectively these 
data show that human endometrium and dermis fibroblasts ex-
press mostly similar levels of adhesion proteins and ECM compo-
nents, with the notable exceptions of fibronectin and collagen IV. 
We further focused on fibronectin. To confirm biochemically the 
RT-qPCR data, we tested cell extracts obtained by direct Laemmli 
buffer lysis of the cell cultures, which therefore contain both cellu-
lar and ECM proteins (Figure 4B, bottom, ECM+C). Quite unex-
pectedly, with regard to the RT-qPCR data, the protein fraction 
corresponding to the ECM and intracellular content of endome-
trium fibroblasts showed a higher fibronectin content than for der-
mis. Because the secreted fibronectin can remain as a soluble pro-
tein in the culture medium, we also analyzed the fibronectin 
content of this protein fraction (Figure 4B, top, fibroblast culture 
supernatant). We found that dermis fibroblasts release much more 
soluble fibronectin in the culture medium than endometrium fibro-
blasts. This high fibronectin protein concentration in the dermis 
culture medium was in agreement with the high fibronectin ex-
pression rate detected in dermis fibroblasts at the RNA level. Of 
importance, it also suggested that fibronectin produced by endo-
metrium and dermis fibroblasts have different properties.
endometrial and dermal fibroblasts (Figure 4). Striking differences 
were observed for fibronectin, however, with a 2.5-fold-higher ex-
pression level in dermis, and for collagen IV, present at low levels 
FIGURE 2: Cytotrophoblast cells display different actin cytoskeleton 
structures, depending on the supporting fibroblast matrix. Placental 
explants were cocultured with either endometrium or dermis 
fibroblasts for 40 h, at which point cells were fixed and stained for 
F-actin, cytokeratin 7, and integrins α5 and α1. (A) F-actin labeling of 
the cocultures shows a strong cortical staining for EVCTs, identified by 
cytokeratin 7 expression, when they migrate on the dermis fibroblast 
layer. (B, C) Integrin α5 (intα5) and α1 (intα1) labeling. Trophoblast 
explants were labeled with a green vital dye before the coculture with 
fibroblasts. After the coculture, cells were fixed and stained with the 
integrin antibodies. Similar results were observed in three 
independent experiments, with villi isolated from different placentas 
and tested on matching sets of dermis and endometrium fibroblasts 
isolated from different donors. Nuclear staining with Hoechst is 
shown in the overlays. Confocal microscopy sections. Arrows indicate 
the direction of EVCT migration. Arrowheads indicate EVCT positions. 
Bar, 50 μm.
FIGURE 3: Endometrium and dermis fibroblasts display different 
characteristics, as exemplified by the vinculin and integrin αV 
expression patterns. The primary human fibroblasts isolated from 
endometrium and dermis tissues were compared for their cell 
morphology, as shown by phase-contrast microscopy, as well as for 
their actin network organization, visualized by rhodamine–phalloidin, 
and vinculin and integrin αV staining. Four matching sets of 
endometrial and dermal fibroblasts were tested and yielded similar 
images. Confocal microscopy sections are shown with nuclei stained 
with Hoechst. Bar, 50 μm; higher magnification, 10 μm.
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isoforms, whose nature was confirmed by the PCR product sequenc-
ing (Figure 5A). To quantify the exon inclusion efficacy, we amplified 
the three FN regions by endpoint RT-PCR and measured the size 
and abundance of each amplicon by capillary electrophoresis using 
Caliper reading stations. For each of the fibronectin alternatively 
spliced regions, the relative abundance of the splicing isoforms was 
determined as a “percent spliced-in” (PSI) value, that is, the ratio of 
concentration of the long amplicon over the sum of those of the 
short and long amplicons (Venables et al., 2013). The level of EDA 
exon incorporation in endometrial fibroblasts was important and 
double the level found in dermis fibroblasts, as measured on RNAs 
isolated from matching sets of fibroblasts from four different donors 
(Figure 5A, right). In contrast, the inclusion rate of the EDB exon was 
low in both endometrium and dermis fibroblasts. There, too, the 
alternative exon inclusion level in dermis fibroblasts was half the 
level found in endometrium fibroblasts. In addition, no difference 
was observed in the splicing profiles of the IIICS alternatively spliced 
region between the two types of fibroblasts. Because of the overall 
low rate of EDB exon inclusion in both endometrial and dermis fi-
broblasts, we further focused on the EDA exon inclusion. Other 
splicing events, besides fibronectin, were compared between endo-
metrium and dermis fibroblasts. Of interest, the inclusion of the FN 
EDA exon in endometrium fibroblasts was near the top of the list of 
events whose splicing varied between endometrium and dermis fi-
broblasts, only second in the series of 46 tested alternatively spliced 
events (Supplemental Table S2) to the use of a 3′ splice site in p53-
induced death domain protein (LRDD) pre-mRNA. Remarkably, 
alternative splicing for LRDD and apoptotic peptidase–activating 
factor 1 (APAF1), the two other genes whose splicing pattern greatly 
differs between dermis and endometrium fibroblasts, showed a 
reverse regulation and was instead favored in dermis fibroblasts. 
Because the EDA+ fibronectin isoform was reported to demonstrate 
higher ECM recruitment capacities than the EDA– isoform (Manabe 
et al., 1997; Abe et al., 2005; Mao and Schwarzbauer, 2005; Zoppi 
et al., 2012), we further tested biochemically the amount of ECM-
bound FN for both types of fibroblasts by performing a deoxy-
cholate extraction of the insoluble matrix (Pankov and Yamada, 
2004). We found indeed that the ECM isolated from endometrium 
fibroblasts contained more fibronectin—both total FN and EDA+ 
FN—than the dermis ECM (Figure 5B). We tested whether we could 
supplement the dermis culture with commercially available plasma 
fibronectin (EDA– FN) so as to increase the FN concentration in the 
ECM, as suggested by previous work (McKeown-Longo and Etzler, 
1987; Peters et al., 1990; Moretti et al., 2007). Addition of increasing 
amounts of plasma fibronectin (5–50 μg) to the culture resulted in 
more fibronectin in the culture medium, as expected (Figure 5C, 
top). As previously described (McKeown-Longo and Etzler, 1987; 
Peters et al., 1990; Moretti et al., 2007), addition of EDA– FN for 8 h 
to the dermis fibroblast culture also resulted in more FN in the pro-
tein fraction containing the ECM and cell content. This increase in 
fibronectin was found to be EDA– and therefore due, indeed, to the 
added plasma fibronectin (Figure 5C, bottom and quantification). 
Using the settings of the coculture, we supplemented the dermis 
culture with exogenous plasma fibronectin (50 μg of pFN [EDA–
]/35-mm dish) 3 d before the protein extraction. We found that, in 
these conditions, the ECM concentrations of FN in the FN-supple-
mented dermis culture increased to levels close to those found in 
the endometrium cultures (Figure 5B). We also observed a slight 
increase in EDA+ FN in the supplemented dermis ECM. Because 
short-term plasma FN supplementation did not show this effect, we 
presume it might be explained by an increased recruitment of the 
EDA+ FN produced by the dermis fibroblasts over the 3-d period, by 
Endometrium and dermis fibroblasts express different 
fibronectin-splicing isoforms that influence the ECM 
fibronectin network
The distinct localization patterns for the fibronectin expressed by 
the endometrium and dermis fibroblasts, added to the known alter-
native splicing regulation of fibronectin, prompted us to further in-
vestigate which FN isoforms were expressed in these cells. RT-PCRs 
were performed on endometrium and dermis fibroblasts with sets 
of primers encompassing the alternatively spliced EDA, EDB, and 
IIICS, respectively (Supplemental Table S1). Analysis of the fibronec-
tin PCR products by gel electrophoresis showed that endometrium 
and dermis fibroblasts express different fibronectin-splicing 
FIGURE 4: Expression of ECM components and adhesion molecules 
by endometrium and dermis fibroblasts. (A) RNAs were prepared 
from two independent cultures for each of four matching sets of 
dermis and endometrium fibroblasts. The relative expression levels of 
extracellular matrix components and adhesion molecules were 
determined by RT-qPCR. Data obtained for each endometrium (•) and 
dermis () primary cell line are plotted, and the corresponding median 
bars are indicated. The ribosomal phosphoprotein RPLP0 and actin 
were used as controls. (B) Protein fractions corresponding to the 
culture supernatants (Sup) and the ECM and cellular proteins (ECM + 
C) from matching sets of endometrium (E) and dermis (D) fibroblasts 
were analyzed by Western blot (left). The fibronectin (FN) and actin 
amount in the ECM+C fraction was quantified with the Odyssey 
system (LI-COR, Lincoln, NE). The fibronectin amounts relative to actin 
are plotted with an indication of the median value for both the 
endometrium (•) and dermis () cultures (right).
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the law of mass action. We also analyzed, by immunofluorescence 
staining, the pattern of the ECM fibronectin generated by endome-
trium and dermis fibroblasts. Of interest, endometrium fibroblast 
cultures produced thick fibronectin bundles, in comparison to the 
fine, fibrillar FN matrix produced by dermis fibroblasts (Figure 5D). 
Double immunofluorescence staining of total and EDA+ fibronectin 
showed that the addition of plasma FN to the dermis fibroblast cul-
ture indeed led to the incorporation of EDA– FN into the ECM. 
Moreover, in several instances, the fine dermis FN structure was 
modified to form endometrium-like FN bundles upon EDA– FN 
supplementation. Taken together, our data show that 1) endome-
trium and dermis fibroblasts express different fibronectin splicing 
isoforms, with a higher EDA exon incorporation rate in endome-
trium compared with dermis; 2) even though endometrial fibroblasts 
express less total fibronectin than dermis, the fibronectin they 
produce generates an extracellular matrix that contains more 
fibronectin and is structured in thicker fibrils than dermis; and 
3) addition of exogenous plasma fibronectin (EDA–) to the dermis 
fibroblast cultures increases their ECM FN content.
Fibronectin-enriched ECM enhances EVCT invasion
To assess the role of fibronectin in the differences observed between 
dermis and endometrium for trophoblast interstitial invasion, we 
supplemented the dermis fibroblasts with fibronectin and tested the 
effects on EVCT migration. Dermis fibroblasts were plated in the 
presence or absence of plasma fibronectin, along with endome-
trium fibroblasts. Three days later, the cocultures were set up as 
previously described, and two sets of phase-contrast pictures were 
taken 24 h apart for each of the three conditions: endometrium, 
dermis, and dermis supplemented with fibronectin (Figure 6A). Data 
obtained with endometrium and dermis fibroblasts confirmed our 
previous observations (Figure 6B; also see Figure 1). Moreover, ad-
dition of fibronectin to the dermis cell layer significantly modified 
trophoblast migration properties (Figure 6B). It lowered the occur-
rence of moving villi from 36 to 15% (p = 0.036). Most of all, it de-
creased the rate of EVCT superficial mass migration from 59 to 37% 
(p = 0.015), thus providing EVCT migration properties close to those 
observed with the endometrial cell matrix.
To dismiss other contributions from fibroblasts in the effects 
we observed, we used an artificial system—a synthetic three-dimen-
sional (3D) collagen I matrix supplemented or not with plasma 
fibronectin—to test the effect of fibronectin on trophoblast 
FIGURE 5: Endometrium and dermis fibroblasts express different 
fibronectin-splicing isoforms, leading to different matrix patterns. 
(A) Fibronectin alternative splicing in endometrium and dermis 
fibroblasts was tested by RT-PCR using primers encompassing the 
alternatively spliced EDA, EDB, and IIICS regions, respectively. The 
PCR products were analyzed by gel electrophoresis (DNA size 
markers in base pairs). The inclusion/exclusion of the exons was 
further confirmed by sequencing of the DNA from the bands marked 
with asterisks. Right, PSI values determined for the three FN exons, 
EDA, EDB, and IIICS, for endometrium (E) and dermis (D) fibroblasts 
obtained from four different donors. (B) Protein samples 
corresponding to the insoluble matrix fractions (deoxycholate 
extraction) from matching sets of endometrium and dermis 
fibroblasts, as well as of the dermis fibroblasts supplemented with 
plasma fibronectin for 3 d (+FN), were analyzed by Western blot, 
using an intermediate filament, lamin A/C, as a loading control. The 
total and EDA-containing fibronectin amounts were quantified with 
the Odyssey system. The fibronectin amounts relative to lamin A are 
plotted. (C) Increasing amounts of plasma fibronectin were added to 
dermis cultures for 8 h. The protein fraction corresponding to the 
culture supernatant (top) and the ECM and cell content (bottom) were 
analyzed for their content in total FN and in EDA+ FN. The amounts 
of FN protein were quantified and are shown in the graph. For total 
FN: 5 μg, p = 0.0481 (*); 10 μg, p = 0.0440 (*); 25 μg, p = 0.00891 (**); 
50 μg, p = 0.0120 (*). No significant differences were found for the 
content in EDA+ FN, with p ranging from 0.6025 to 0.9237. 
(D) Endometrium and dermis fibroblasts were seeded in the same 
conditions as for the cocultures. For the fibronectin supplementation 
conditions (dermis+ FN), pFN was added to dermis fibroblasts at the 
time of the culture. Four days later, cultures were fixed and stained 
for total fibronectin (FN total), EDA-containing fibronectin (FN– EDA), 
and Hoechst (shown in the overlays). Confocal microscopy sections. 
Bar, 100 μm; higher magnification, 20 μm. Arrows show FN that is 
presumably EDA–, as it was bound by the anti-FN antibody (stained in 
red) and not by the anti–FN EDA antibody.
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domain but instead a high fibronectin con-
centration within the matrix that is essential 
for migration.
The high expression level of SRSF1 in 
endometrium contributes to FN EDA 
exon inclusion
To determine the reason for the higher in-
corporation rate of the EDA exon in endo-
metrium fibroblasts, we focused on SR pro-
teins, a family of proteins involved in the 
regulation of alternative splicing. Because 
their activity depends on their phosphoryla-
tion status, we first compared the phospho-
rylation patterns of SR proteins in endome-
trium and dermis fibroblasts using the 
mAb104 antibody, which recognizes a phos-
phoserine epitope in the RS domain of SR 
proteins (Zahler et al., 1993). We observed a 
stronger signal in the endometrial cell lines 
tested than in their matching dermal coun-
terparts (Figure 8A). This difference was 
specific to SR proteins because the phos-
phorylation levels of the extracellular signal-
regulated protein kinase ERK, tested in the 
same protein extracts, showed no differ-
ence. We further focused on the SR protein 
SRSF1, which has extensively been shown to 
favor the inclusion of the fibronectin EDA 
domain (Mermoud et al., 1994; Cramer 
et al., 1997, 1999; Misteli et al., 1997, 1998; 
Kadener et al., 2002; Nogués et al., 2003; 
Blaustein et al., 2009; Chen and Manley, 
2009; de la Mata et al., 2010; White et al., 
2010). Preparing cell extracts from endome-
trium and dermis fibroblasts, we found a 
twofold higher SRSF1 protein expression 
level in endometrium than in dermis (Figure 
8B). Because the localization and in vivo ac-
tivity of SR proteins depend on their phosphorylation status, we in-
vestigated SRSF1 phosphorylation by two-dimensional (2D) gel 
electrophoresis. Indeed, previous studies on various cell lines in our 
laboratory showed that SRSF1 can be distributed in at least 10 dif-
ferent spots in 2D gels, corresponding to different phosphorylation 
isoforms. Most of the phosphorylation sites are in the RS domain 
containing the SR repeats. Comparing extracts from endometrium 
and dermis fibroblasts, we observed similar spots, at the same mi-
gration distance, for endometrial and dermal extracts, which implied 
the same extent of phosphorylation of SRSF1 (Figure 8C). The stron-
ger SRSF1 signal in the endometrium extracts was also in agree-
ment with the twofold-higher SRSF1 protein concentration found in 
endometrium compared with dermis (Figure 8B).
To determine whether the higher expression levels of SRSF1 ob-
served in endometrial fibroblasts were responsible for the increased 
EDA exon incorporation, we tested the effect of SRSF1 silencing in 
these cells. RNA interference–mediated depletion of SRSF1 led in-
deed to a twofold reduction of the EDA+ fibronectin protein con-
centration while having no effect on the total fibronectin concentra-
tion (Figure 9A). This reduced inclusion of the EDA alternative exon 
in response to SRSF1 silencing was also observed at the RNA level 
(Figure 9, B and C). The effects of SRSF1 depletion on exon inclu-
sion were performed and quantified by capillary electrophoresis 
migration. Placental explants were embedded in the matrix and, 
within 24–48 h, released EVCTs that could migrate away from the 
explants. On the basis of phase-contrast images of the cultures 
taken at day 4, EVCT migration phenotypes were classified into 
three categories: “isolated” migration achieved by EVCTs that mi-
grated as single cells in all directions, “packed” EVCT migration 
occurring mainly in a single direction with few isolated cells, and “no 
migration” for EVCTs demonstrating a low capacity to migrate away 
from the trophoblast villi (Figure 7A). The statistical analysis was per-
formed on EVCTs produced by villi dissected from four different pla-
centas. Whereas isolated EVCT 3D migration was achieved for only 
25% of villi in the collagen I matrix, supplementation of the matrix 
with fibronectin raised this proportion to roughly 50% (Figure 7B). 
Conversely, the percentage of villi displaying a low migration phe-
notype decreased twofold on addition of fibronectin. The percent-
age of villi producing EVCTs of the “packed” phenotype remained 
unchanged on addition of fibronectin. These data show that addi-
tion of fibronectin within the matrix enhances isolated EVCT 3D mi-
gration, that is, EVCT invasion capacity. Together these data, in ad-
dition to those obtained in the coculture settings, support a role for 
fibronectin in providing an adequate matrix for interstitial EVCT mi-
gration. Of importance, the fact that plasma fibronectin (EDA–) can 
enhance migration indicates that it is not the presence of the EDA 
FIGURE 6: Fibronectin supplementation of the dermis cell layer enhances trophoblast interstitial 
migration. Cocultures were set up between human trophoblast explants and endometrial 
fibroblasts, dermal fibroblasts, or dermal fibroblasts supplemented with plasma fibronectin. 
After 16 h of coculture, phase-contrast pictures were taken (T0) and again 24 h later (T24h). 
(A) Phase-contrast micrographs show interstitial EVCT migration for cocultures on endometrium 
and fibronectin-supplemented dermis fibroblasts and superficial EVCT mass migration 
(refringent packed EVCTs) in dermis coculture conditions. (B) The type of EVCT migration 
(superficial vs. interstitial), as well as the occurrence of trophoblast villi movement, were 
analyzed in the three coculture conditions. Data points corresponding to each of the 
independent cultures are plotted, and the median values are indicated. Two-tailed p values were 
determined with the Mann–Whitney rank sum test. For villi movement, **p = 0.007, *p = 0.036; 
for EVCT migration, **p = 0.002, *p = 0.015.
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higher EDA exon incorporation rate in 
endometrium.
DISCUSSION
The stromal microenvironment influences 
epithelial cell migration. We tested here 
whether fibroblasts from different tissues 
display similar capacities to support migra-
tion. Instead of the interstitial trophoblast 
migration previously observed on endome-
trium (Fafet et al., 2008), we observed su-
perficial EVCT migration on dermis. We 
found that fibronectin is differently provided 
by endometrium and dermis and greatly re-
sponsible for these differences. Moreover, 
the higher EDA inclusion rate in endome-
trium fibronectin can be explained, at least 
in part, by the higher concentrations of the 
splicing factor SRSF1. Our data thus estab-
lish a relationship between the capacity of a 
tissue to support invasion, the regulation of 
alternative splicing, and the expression level 
of splicing factors.
We showed that addition of plasma FN 
(EDA–) enhanced the invasive capacity of 
EVCTs, in both the fibroblast coculture sys-
tem and a 3D collagen I matrix. These data 
suggest that the documented trophoblast-
secreted fibronectin (Feinberg et al., 1991; 
Bischof et al., 1995; Aplin et al., 1999) is not 
sufficient to modify the ECM structure and 
ensure its own migration. Additional contri-
butions from the stroma-derived matrix are 
required. They also show that EVCT intersti-
tial migration requires high fibronectin con-
centrations but not the EDA exon, as sup-
plementation of the culture with plasma 
fibronectin (deprived of the EDA domain) 
can recapitulate matrix properties of the en-
dometrium fibroblasts. This raises the ques-
tion of why dermis fibroblasts, which express high concentrations of 
EDA– fibronectin, cannot provide an ECM proper to support tro-
phoblast interstitial migration. Our hypothesis for this apparent dis-
crepancy is that, although EDA– FN demonstrates a capacity to in-
corporate within the insoluble ECM, as previously demonstrated 
(Moretti et al., 2007) and confirmed here, this fibrillogenesis capac-
ity is much poorer than that of the EDA+ FN (Guan et al., 1990; Abe 
et al., 2005). This explains why dermis-derived fibronectin is ob-
served in high amounts in the culture supernatant but in low amounts 
in the insoluble matrix. It can also explain to some extent why, de-
spite their higher fibronectin RNA expression levels, dermis fibro-
blasts generate a fibronectin matrix less prone than that of endome-
trium to promote EVCT invasion. Other factors may contribute to 
the differences observed between endometrium and dermis FN 
networks. Because FN interacts with other matrix components, such 
as collagens, in the process of fibrillogenesis (Kadler et al., 2008), 
the different expression levels of collagen IV in endometrium and 
dermis might also contribute to the distinct FN networks observed 
and, in a more general manner, to different matrix structures for en-
dometrium and dermis. FN assembly is a cell-mediated process that 
depends on the cytoskeleton traction forces, and therefore the dy-
namic interactions between FN and the actin cytoskeleton at the 
at the high-throughput PCR platform of Sherbrooke University 
(Sherbrooke, Canada). Despite higher overall PSI values than ours, 
presumably due to different reaction conditions and primer se-
quences (Supplemental Table S3), similar differences in the EDA in-
clusion rate between endometrium and dermis were observed. Of 
importance, SRSF1 depletion showed a twofold decrease of the FN 
EDA PSI value, whereas the inclusion of the EDB exon remained 
unchanged (Figure 9, B and C). The EDA exon skipping induced by 
the SRSF1 knockdown represented the third-most-changed alterna-
tive splicing event among the 46 splicing events tested, just after 
the alternative splicings of LRDD and APAF1. It is worth noting that 
insulin receptor (INSR) was also in the top list of genes whose exon 
inclusion was affected by SRSF1 depletion, as the inclusion of INSR 
exon 11, like that of FN EDA, is enhanced by SRSF1 (Sen et al., 
2009). These data show that inclusion of the FN EDA exon in endo-
metrium fibroblasts is linked to the expression levels of the SR pro-
tein SRSF1. Overall our data show that the higher capacity of endo-
metrium fibroblasts to support interstitial EVCT migration is due to 
their capacity to produce a matrix enriched in fibronectin, which is 
linked to the expression of the EDA-containing fibronectin isoform 
(Figure 10). We provide a mechanism by which the higher SRSF1 
cellular concentrations in endometrial fibroblasts contribute to this 
FIGURE 7: Fibronectin supplementation of a synthetic 3D collagen I matrix promotes isolated 
trophoblast cell migration. Trophoblastic villi were embedded within a 3D collagen I matrix (coll 
I) supplemented with plasma fibronectin when indicated (coll I/Fn). At day 4, phase-contrast 
pictures of the cultures were taken. Three types of EVCT migration were identified for coll I/Fn 
cultures (A; schematized in B): “isolated” migration, corresponding to the migration of single 
EVCTs in all directions; “packed” cell migration; and “no migration,” for EVCTs showing a low 
capacity to migrate away from the trophoblastic villi. Bar, 100 μm. (B) Statistical analysis of EVCT 
migration in coll I and coll I/Fn 3D culture conditions. Data were obtained with villi isolated from 
four placentas (>100 trophoblastic villi analyzed in each condition). For each placenta, the 
number of villi giving rise to each type of EVCT migration was rated and is expressed as a 
percentage of the total number of villi for this placenta. The median value is indicated for 3D 
cultures performed in collagen I (•) or in collagen I supplemented with plasma fibronectin ().
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fibrillar adhesions also play an important role (Mao and Schwarz-
bauer, 2005; Frantz et al., 2010). Given that endometrium and 
dermis fibroblasts display distinct labeling patterns for both vinculin 
and integrin αV, an integrin also involved in FN fibril assembly (Leiss 
et al., 2008), these interactions could differ in these two types of fi-
broblasts and also contribute to differences in their respective FN 
fibril meshworks.
We found that expression levels of most of the tested adhesion 
proteins and ECM components were similar in dermis and endome-
trium fibroblasts, with the notable exceptions of fibronectin and col-
lagen IV. Previous studies on fibroblasts from distinct anatomical 
sites underlined the existence of site-specific gene expression pro-
grams (Chang et al., 2002; Rinn et al., 2006). We found, as they did, 
that tissue-dependant differences surpassed donor-to-donor differ-
ences. In addition, the expression of the EDA+ FN splicing isoform 
in endometrium, a tissue that undergoes cyclical regeneration, is 
consistent with the documented expression of EDA+ FN in adult 
tissues in response to injury (Ffrench-Constant et al., 1989; Muro 
et al., 2003). Of interest, the alternatively spliced EDA domain is also 
highly expressed in the neovasculature of metastases, underlying its 
role in host tissue invasion (Rybak et al., 2007).
Our data emphasize the possible discrepancies between gene 
expression levels and their biological effects due to the occurrence 
of alternative splicing, a mechanism likely to relate to >90% of the 
human genes (Johnson et al., 2003; Wang et al., 2008; Barash et al., 
2010). Alternative mRNA splicing depends on complex mechanisms 
that involve not only spliceosome assembly, but also regulation by 
SR proteins, coupling between transcription and splicing machiner-
ies, and epigenetic regulation (Kadener et al., 2001; Nogues et al., 
2002; Chen and Manley, 2009; Hartmann and Valcarcel, 2009; Luco 
et al., 2010, 2011; Munoz et al., 2010). Inclusion of the EDA domain 
in human fibronectin is facilitated by the SR protein SRSF1, as previ-
ously demonstrated (Cramer et al., 1999; Buratti and Baralle, 2004; 
Chen and Manley, 2009; de la Mata et al., 2010) and confirmed here 
in endometrium fibroblasts. We found twofold higher expression 
levels of SRSF1 in endometrium than in dermis, a modest difference 
nonetheless sufficient to provide a transformed phenotype to im-
mortal murine fibroblasts (Karni et al., 2007). Because SRSF1 activity 
also depends on its phosphorylation pattern and AKT-dependent 
SRSF1 phosphorylation results in increased EDA exon inclusion 
(Blaustein et al., 2005), we checked SRSF1 phosphorylation rates in 
dermis and endometrium fibroblasts and found no difference. Re-
ports suggest that SRSF1 can be regulated by other posttransla-
tional modifications, such as arginine methylation (Sinha et al., 
2010), or posttranscriptional processes, such as nonsense-mediated 
mRNA decay (Sun et al., 2010; Valacca et al., 2010). Determining 
whether such mechanisms can further differentiate SRSF1 activity in 
dermis and endometrium fibroblasts requires further investigation.
Other SR proteins, such as SRSF7 (9G8) (Cramer et al., 1999) and 
SRSF5 (SRp40; Kuo et al., 2002), as well as splicing factors, notably 
SPF45 (Al-Ayoubi et al., 2012), can favor EDA exon inclusion in some 
tissues, as seen for SRSF5 in chondrocytes but not HeLa cells. Our 
comparison of SR protein expression/phosphorylation patterns in 
dermis and endometrium, using the mAb104 antibody, showed sig-
nificant differences between dermis and endometrium fibroblasts, 
which presumably relate to other SR proteins than SRSF1. Because 
small interfering RNA (siRNA) depletion of SRSF1 in endometrium 
led to a twofold decrease of the EDA PSI value, reaching levels close 
to that of dermis, however, SRSF1 most likely plays a major role for 
EDA exon inclusion in these cells.
In conclusion, the differential fibronectin splicing between der-
mis and endometrium described here and the resulting differential 
FIGURE 8: Concentration and phosphorylation levels of the SR 
protein SRSF1 in endometrium and dermis fibroblasts. Cell extracts 
were prepared from matching sets of primary endometrial (E) and 
dermal (D) fibroblasts and analyzed by Western blotting. (A) Proteins 
were probed with antibodies recognizing phosphorylated SR proteins 
(mAb104), glyceraldehyde-3-phosphate dehydrogenase as well as 
ERK in both its phosphorylated and unmodified states. (B) The relative 
amount of SRSF1 protein was quantified with the Odyssey Infrared 
Imaging system, using actin levels to normalize. Data points from five 
independent experiments performed with endometrium (•) and 
dermis () are plotted, and the median value is indicated. The 
two-tailed p value was determined with the Mann–Whitney rank sum 
test. ***p = 0.0003. (C) The phosphorylation pattern of SRSF1 in 
endometrium and dermis fibroblasts was determined by 2D gel 
electrophoresis. The pH range and the molecular weight markers (in 
kilodaltons) are indicated.
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siveness to epithelial cell invasion. Alterna-
tive splicing is regulated according to cell 
type. We show here that, even for the same 
cell type, alternative splicing can differ and 
depend on the tissue of origin of these cells. 
We propose that the mechanisms brought 
to light here for EVCT invasion might apply 
as well to other types of epithelial cell inva-
sion, thus opening new avenues for under-
standing the complex role played by the 
stroma in tissue invasion. In the case of 
pathological processes such as cancer pro-
gression, such mechanisms might contrib-
ute to the selected tropism of metastases 
(Barkan et al., 2010). It also will be worth 
asking whether the known interactions be-
tween cancer and stromal cells might modify 
SRSF1 expression rate in the latter and fur-
ther promote cancer cell invasion.
MATERIALS AND METHODS
Patients and samples
Endometrial and subpubic dermal tissues 
were obtained from pregnant women (n = 4) 
undergoing C-sections at the Hospital Ar-
naud de Villeneuve, Montpellier, France. 
They were at term for a normal pregnancy. 
Trophoblast villi were isolated from placen-
tas (n = 14) obtained from legal early preg-
nancy terminations of uncomplicated, un-
wanted pregnancies. Abortions were 
induced by mifepristone. All samples were 
obtained at 4- to 7-wk gestational age. 
Pregnancy was dated by echography and 
measurement of both the crown–rump 
length and mean gestational sac diameter. 
All samples were obtained after informed 
written consent of the patients, and the pro-
tocol was approved by the local ethics com-
mittee. For the isolation of human fibro-
blasts, 2-mm-long endometrium and dermis 
explants were mechanically chopped and 
seeded on 6-cm dishes in DMEM supple-
mented with 10% heat-inactivated fetal bo-
vine serum (FBS). These fibroblasts were 
passaged twice a week and used before 
passage 6. All human primary cell lines of 
dermis and endometrium fibroblasts were 
checked to be mycoplasma free. They were 
positive for vimentin expression.
Establishment of cocultures
Cocultures were established as described 
previously (Fafet et al., 2008). Briefly, after 
uterine evacuation, placentas were immedi-
ately collected in “DMEM medium”: DMEM 
supplemented with heat-inactivated FBS 
10%, fluconazole (4 μg/ml; Pfizer, New York, 
NY), and amphotericin B (20 μg/ml; Bristol-
Myers Squibb, New York, NY). Before dissection, placentas were 
gently washed with warm phosphate-buffered saline (PBS) to elimi-
nate blood. Placental villosities were dissected with sterile tweezers 
ECM capacity to support trophoblast migration provide an example 
of how components of the stroma can undergo different alternative 
splicing regulation and consequently demonstrate distinct permis-
FIGURE 9: Silencing of SRSF1 in endometrium reduces inclusion of fibronectin EDA exon. 
(A) For silencing experiments, transfections were performed with two SRSF1-targeting siRNAs 
(siRNA1 and siRNA2), as well as with a scrambled siRNA (siRNA scr), which was used as a 
control. Data obtained with cells recovered 3 d after the siRNA transfection (similar data were 
obtained with two rounds of 3-d transfections, with cells collected at day 6). Total protein 
extracts were analyzed by Western blotting for total FN, FN containing the EDA domain, SRSF1, 
and, as a loading control, γ-tubulin. Relative protein values were normalized to γ-tubulin 
concentrations. (B) Fibronectin alternative splicing in each condition was tested by RT-PCR, using 
primers encompassing the alternatively spliced EDA and EDB domains. PCR products were 
analyzed by gel electrophoresis. (A, B) Mean values with SEM. The p values were determined by 
a paired t test: for FN EDA, p = 0.013 (*); for FN EDB, p = 0.058 (ns). (C) In addition, control and 
siRNA-treated RNA samples (n = 4 per group) were compared at the Sherbrooke RNomics 
platform to determine PSI for 46 alternative splicing events, including the EDA and EDB exon 
alternative splicings. The results are presented as a heat map showing the unsupervised 
hierarchical clustering of the change in splicing (ΔPSI = PSI value of the control endometrium − 
PSI value of the SRSF1-depleted endometrium). Splicing changes (ΔPSI values) are represented 
in shades of bright green (exon skipping upon SRSF1 depletion) to red (exon inclusion), as 
schematized in the color key histogram.
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concentration of 5 μg/ml. A first layer of col-
lagen matrix was deposited in the wells and 
incubated at 37°C. Placental 1-mm-long ex-
plants were then deposited on the matrix, 
and a second layer of collagen matrix was 
poured on top of the explants. The wells 
were then filled with DMEM supplemented 
with FBS 5% and incubated at 37°C.
siRNA transfection
siRNAs directed against SRSF1 were trans-
fected at a concentration of 100 nM with 
Oligofectamine reagent (Invitrogen, Carls-
bad, CA) according to the manufacturer’s 
instructions. Briefly, the day before transfec-
tion endometrial fibroblasts (105 cells) were 
seeded in 35-mm dishes in DMEM supple-
mented with FBS 10%. Fibroblasts were 
∼40% confluent the day of transfection. Cell 
culture media was replaced by 800 μl of se-
rum-free Opti-MEM medium (Invitrogen) 
before transfection. A mixture of 10 μl of siR-
NAs (10 μM) diluted in 175 μl of Opti-MEM 
and 4 μl of Oligofectamine diluted in 7.5 μl 
of Opti-MEM was incubated for 10 min at 
room temperature, then mixed gently and 
further incubated for another 15 min before 
addition dropwise to the cells. The cells 
were incubated 4 h at 37°C before addition 
of DMEM supplemented with FBS 10%. 
Cells were recovered 72 h after transfection 
for RNA or protein extraction (day 3 experi-
ments) or reseeded to undergo a second 
round of transfection (day 6 experiments). 
Sequences used are the following: siRNA 
scrambled, 5′-GUG-AAG-CGC-AAG-UAG-
ACU-AdTdT-3′ and 5′-UAG-UCU-ACU-UGC-
GCU-UCA-CdTdT-3′; siRNA 1, 5′-GGG-
UAG-CAA-UGC-CAG-UAA-AdTdT-3′ and 
5′-UUU-ACU-GGC-AUU-GCU-ACC-CdTdT-3′; siRNA 2, 5′-GAA-
AGA-AGA-UAU-GAC-CUA-UdTdT-3′ and 5′-AUA-GGU-CAU-AUC-
UUC-UUU-CdTdT-3′.
Determination of the percent splicing index
The RNA samples were analyzed by the RNomics platform of Sher-
brooke University (http://lgfus.ca/public/fr/node/22). A total of 46 
alternative splicing units were tested by endpoint PCR. Microcapil-
lary electrophoresis (using the LabChip HT DNA assay on a Caliper 
[Hopkinton, MA] automated microfluidic station) was used for the 
detection and characterization of alternative splicing events. The 
relative concentrations of alternatively spliced mRNA isoforms were 
determined, and the PSI was calculated. For bioinformatic analysis, 
Ward hierarchical clustering using an Euclidean distance metric was 
done using R-based open-access software (www.r-project.org/; 
www.hiv.lanl.gov/content/sequence/HEATMAP/heatmap.html).
Imaging
Time-lapse analysis of trophoblastic cell invasion was done with a 
phase-contrast Leica DMIR (Leica, Wetzlar, Germany) in an incubation 
chamber providing controlled temperature, CO2 concentration, and 
hygrometry. Pictures were taken every 8 min for 24-48 h using an 
ORCA 100 (Hamamatsu, Hamamatsu, Japan) and the HPDCPx32 
and scissors to get tissue pieces ∼1 mm long. Villosities were then 
rinsed once and resuspended in DMEM/Ham medium: 50% of 
DMEM and 50% of Ham F12 medium supplemented with CaCl2 (2 
mM), MgSO4 (2 mM), and NaHCO3 (0.5 mM). Three days before 
the coculture, the endometrial and dermal fibroblasts were seeded 
on glass coverslips (105 cells in 35-mm-diameter dishes) in DMEM 
supplemented with FBS 10% so that fibroblasts were confluent by 
the time cocultures were started. Before setting up the cocultures, 
the fibroblast medium was changed to DMEM/Ham medium. Ap-
proximately 10 trophoblast explants were seeded per 35-mm dish 
and let to adhere for 16 h at 37°C. At that point, the medium was 
aspirated, and plates were rinsed once with the DMEM/Ham me-
dium to eliminate all unattached villosities and further incubated in 
the same medium. This was considered to be time zero for all anal-
yses of trophoblast migration. When appropriate, the supplemen-
tation of dermal fibroblasts with fibronectin (human plasma FN; BD 
Biosciences, San Jose, CA) was done at the time of fibroblast seed-
ing with the addition of 50 μg of fibronectin/35-mm dish.
In vitro 3D cultures
The 3D cultures were set in 48-well plates. Collagen I was used at a 
final concentration of 1.5 mg/ml. When indicated, fibronectin (hu-
man plasma FN; BD Biosciences) was mixed with collagen at a final 
FIGURE 10: Mechanisms for the different capacities of endometrium and dermis tissues to 
support trophoblast invasion. 1) Endometrium fibroblasts produce higher concentrations of the 
SR protein SRSF1 than dermis fibroblasts, which leads 2) to higher inclusion rates of the EDA 
exon in the fibronectin produced by endometrium and consequently 3) to an endometrium 
extracellular matrix that contains more and thicker fibronectin bundles than dermis. 4) This 
results in a better capacity for the endometrium tissue than for dermis to support trophoblast 
invasion.
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program. After imaging, all time points were compiled and exported 
as a QuickTime (Apple, Cupertino, CA; avi) file using MetaMorph 
software (Molecular Devices, Sunnyvale, CA). Alternatively, images 
were taken with a DMIRE 2 2002 microscope (Leica) and a MicroMax 
1300Y/HS (19xx) camera (Roper Scientific, Trenton, NJ) with the Meta-
Morph 7 acquisition program. For phase-contrast microscopy of both 
cocultures and 3D cultures, photographs were taken on an Axiovert 
25 inverted-phase microscope (Carl Zeiss, Jena, Germany) coupled to 
a digital PowerShot camera (Canon, Melville, NY). The digitalized im-
ages were mounted using Photoshop (Adobe, San Jose, CA). Immu-
nofluorescence and CellTracker stainings were visualized with a Zeiss 
LSM 510 Meta confocal laser system. Images were converted with 
MetaMorph and processed with Photoshop software.
Data statistical analysis
Sample comparison was performed using the Mann–Whitney rank 
sum test. Statistical analysis and data plots were performed using 
Prism software (GraphPad, San Diego, CA). *p ≤ 0.05; **p ≤ 0.01; 
***p ≤ 0.001.
Miscellaneous
A detailed description of cytoimmunofluorescence, protein analysis, 
and RNA quantification (RT-qPCR) conditions is given in the Supple-
mental Experimental Procedures.
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